TAIFLEX Scientific Co., Ltd. (8039) Stock Statistics & Valuation Metrics
Total Valuation
TAIFLEX Scientific Co., Ltd. has a market cap or net worth of TWD 49.99B. The enterprise value is TWD 77.41B.
- Market Cap
- TWD 49.99B
- Enterprise Value
- TWD 77.41B
Share Statistics
TAIFLEX Scientific Co., Ltd. has 263,804,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 263,804,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TAIFLEX Scientific Co., Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.59%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 3.59%
- Return on Capital Employed (ROCE)
- 0.04
- Revenue Per Employee
- 8.56M
- Profits Per Employee
- 431.90K
- Employee Count
- 1,239
- Asset Turnover
- 0.72
- Inventory Turnover
- 4.78
Valuation Ratios
The current PE Ratio of TAIFLEX Scientific Co., Ltd. is 61.73. TAIFLEX Scientific Co., Ltd.’s PEG ratio is 0.52.
- PE Ratio
- 61.73
- PS Ratio
- 4.83
- PB Ratio
- 4.55
- Price to FCF
- 40.53
- Price to Operating Cash Flow
- 26.56
- PEG Ratio
- 0.52
Income Statement
In the last 12 months, TAIFLEX Scientific Co., Ltd. had revenue of 10.61B and earned 535.12M in profits. Earnings per share was 2.07.
- Revenue
- 10.61B
- Gross Profit
- 1.94B
- Operating Income
- 506.79M
- Pretax Income
- 614.75M
- Net Income
- 535.12M
- EBITDA
- 1.05B
- Earnings Per Share (EPS)
- 2.07
Cash Flow
In the last 12 months, operating cash flow was 1.92B and capital expenditures -681.96M, giving a free cash flow of 1.23B billion.
- Operating Cash Flow
- 1.92B
- Free Cash Flow
- 1.23B
- Free Cash Flow per Share
- 4.59
Dividends & Yields
TAIFLEX Scientific Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.05%
- Dividend Per Share
- ―
- Dividend Yield
- 1.05%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.47%
- Earnings Yield
- 1.59%
Stock Price Statistics
- Beta
- 1.08
- 52-Week Price Change
- 184.11%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 29.52
- Average Volume (3m)
- 31.03M
Important Dates
TAIFLEX Scientific Co., Ltd. upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
TAIFLEX Scientific Co., Ltd. as a current ratio of 2.94, with Debt / Equity ratio of 8.45%
- Current Ratio
- 2.94
- Quick Ratio
- 2.36
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -1.86
- Interest Coverage Ratio
- 22.44
Taxes
In the past 12 months, TAIFLEX Scientific Co., Ltd. has paid 89.73M in taxes.
- Income Tax
- 89.73M
- Effective Tax Rate
- 0.15
Enterprise Valuation
TAIFLEX Scientific Co., Ltd. EV to EBITDA ratio is 40.97, with an EV/FCF ratio of 39.13.
- EV to Sales
- 4.66
- EV to EBITDA
- 40.97
- EV to Free Cash Flow
- 39.13
- EV to Operating Cash Flow
- 25.19
Balance Sheet
TAIFLEX Scientific Co., Ltd. has TWD 3.22B in cash and marketable securities with TWD 1.29B in debt, giving a net cash position of TWD 1.94B billion.
- Cash & Marketable Securities
- TWD 3.22B
- Total Debt
- TWD 1.29B
- Net Cash
- TWD 1.94B
- Net Cash Per Share
- TWD 7.34
- Tangible Book Value Per Share
- TWD 41.26
Margins
Gross margin is 20.82%, with operating margin of 5.81%, and net profit margin of 7.82%.
- Gross Margin
- 20.82%
- Operating Margin
- 5.81%
- Pretax Margin
- 9.21%
- Net Profit Margin
- 7.82%
- EBITDA Margin
- 11.38%
- EBIT Margin
- 5.81%
Analyst Forecast
The average price target for TAIFLEX Scientific Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.53%
- EPS Growth Forecast
- 118.11%
